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Background. Multimorbidity in non-communicable diseases (NCDs) is a complex global healthcare challenge that is becoming increasingly 
prevalent. In Africa, comorbidity of communicable diseases and NCDs is also increasing.
Objectives. To evaluate the extent of multimorbidity among patients with NCDs in South African (SA) primary healthcare (PHC).
Methods. A dataset obtained from a previous morbidity survey of SA ambulatory PHC was analysed. Data on conditions considered active 
and ongoing at consultations by PHC providers were obtained.
Results. Altogether 18 856 consultations were included in the dataset and generated 31 451 reasons for encounter and 24 561 diagnoses. 
Hypertension was the commonest NCD diagnosis encountered (13.1%), followed by type 2 diabetes (3.9%), osteoarthritis (2.2%), asthma 
(2.0%), epilepsy (1.9%) and chronic obstructive pulmonary disease (COPD) (0.6%). The majority of patients (66.9%) consulted a nurse and 
33.1% a doctor. Overall 48.4% of patients had comorbidity and 14.4% multimorbidity. Multimorbidity (two or more conditions) was present 
in 36.4% of patients with COPD, 23.7% with osteoarthritis, 16.3% with diabetes, 15.3% with asthma, 12.0% with hypertension and 6.7% with 
epilepsy. Only 1.1% also had HIV, 1.0% TB, 0.4% depression and 0.04% anxiety disorders.
Conclusion. About half of the patients with NCDs had comorbidity, and multimorbidity was most common in patients with COPD 
and osteoarthritis. However, levels of multimorbidity were substantially lower than reported in high-income countries. Future clinical 
guidelines, training of PHC nurses and involvement of doctors in the continuum of care should address the complexity of patients with 
NCDs and multimorbidity.
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Non-communicable diseases (NCDs) are the leading 
cause of global mortality, and their prevalence is 
rising in low- and middle-income countries.[1] This 
is because of increasing life expectancy, urbanisation 
and globalisation of the food industry, which drive the 
four main underlying risk factors of unhealthy diet, physical inactivity, 
tobacco smoking and harmful use of alcohol.[1]
In sub-Saharan Africa, communicable diseases such as HIV, 
tuberculosis (TB) and malaria have been the leading causes of death 
in the past.[2] However, because of the prevention and treatment of 
communicable diseases, particularly HIV, which is now seen as a chronic 
disease, life expectancy is increasing and enables the emergence of NCDs 
in middle age.[2] In developing countries, the age of onset of NCDs is 
younger than in developed countries, and, because of their early age of 
onset, they lead to more premature deaths.[3] Communicable diseases 
and NCDs are also interconnected and there is, for example, evidence of 
a relationship between the treatment of HIV/AIDS and cardiometabolic 
disorders; between smoking, diabetes and tuberculosis; and between 
smoking, TB and chronic obstructive pulmonary disease (COPD).[4]
The South African (SA) healthcare system faces a quadruple burden 
of disease, characterised by HIV/AIDS and TB, injury and violence, 
maternal and child health issues, and NCDs.[2] Currently NCDs are 
estimated to contribute 28% to the total burden of disease, and this 
is predicted to increase substantially over the next few decades if 
measures are not taken to combat the trend.[2] In the Western Cape, 
NCDs make up five of the ten leading causes of death: ischaemic heart 
disease, diabetes, cerebrovascular disease, lung cancer and COPD.[5] 
The World Health Organization estimates the burden of NCDs to be 
two to three times higher in SA than in high-income countries.[6] The 
distribution of NCDs displays socioeconomic disparities, with the 
heaviest burden among poor communities in urban areas. The rising 
morbidity and mortality related to NCDs have major implications for 
the delivery of both acute and chronic healthcare services.[2] In addi-
tion, NCDs have economic consequences for individuals, households 
and society, and are therefore also a developmental challenge.[6]
Primary healthcare (PHC) is the foundation of the SA healthcare 
system and where the majority of patients with NCDs are managed, 
usually by nurses.[7] The most common NCDs are hypertension, 
diabetes, asthma, osteoarthritis, COPD and epilepsy.[7] NCDs 
are generally poorly managed and controlled.[6] Poorly organised 
healthcare systems, intermittent disruption of drug supplies and 
lack of capability to manage NCDs on the part of healthcare workers 
(HCWs) all contribute to patient morbidity and mortality.[8]
In high-income countries with elderly populations, the issue 
of multimorbidity has become a major challenge. In Scotland, for 
example, over half of the population over the age of 65 years have two 
or more NCDs.[9] Effective management of multimorbidity and NCDs 
may require a shift from problem-orientated to goal-orientated care.[10] 
This means that treatment of patients with multimorbidity should be 
tailored to each individual patient, that each patient’s socioeconomic 
circumstances and preferences should be taken into account, and 
that protocols should not be followed blindly.[11] Furthermore, general 
practitioners believe that using approaches focused on a single disease 
is not adequate when multiple conditions and their recommended 
treatments need to be brought together and priorities established, 
which is a complex task. In people with multimorbidity, some decisions 
will still be made within a single-disease framework, but decision-
making will often require balancing competing considerations.[11]
At any one moment, there may be a single condition that dominates 
the clinical picture in a patient with multimorbidity, but over time 
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this often changes. Additionally, where a 
patient has many conditions, single-disease 
guideline recommendations are sometimes 
discordant. Different courses of action may be 
contradictory, for example, prescribing a short 
course of steroids to a patient with asthma and 
diabetes, in which situation the multimorbidity 
creates complexity that requires clinical 
judgement beyond that offered in guidelines.
In the SA context, there is active debate 
on how to integrate chronic care for HIV, 
which is currently organised as a separate 
vertical service, with TB services and with 
NCDs. HCWs anticipate a scenario in which 
large numbers of people have concurrent 
communicable and non-communicable 
diseases that need to be treated, and 
controlled, in an integrated approach. This 
study, which is based on a national PHC 
morbidity survey,[7] aimed to measure the 
current degree of multimorbidity among 
patients diagnosed with NCDs in SA.
Methods
Study design
The study analysed a dataset obtained from a 
previous morbidity survey of SA PHC.[7] The 
design of the study from which the dataset 
was derived is outlined below.
Setting 
The original study was implemented during 
2010 in PHC facilities in the Western Cape, 
North West, Northern Cape and Limpopo 
provinces of SA. These provinces were 
chosen because postgraduate students were 
available to act as research assistants and 
because they traversed the country from 
east to west and north to south. Sequential 
ambulatory patients who presented to nurses 
or doctors were included in the study.
Sampling and sample size
The sample size was based on: (i) the number 
of HCWs a research assistant could train and 
support across a number of facilities; and 
(ii) ensuring that the secondary encounters 
would occur in large enough numbers. The 
sample size per province was therefore the 
product of the number of HCWs that could 
be handled (60), the number of sampling 
days for each HCW (5) and the number 
of patients per day (20), resulting in 6 000 
encounters per province and 24 000 overall.
One district was purposefully selected from 
each province, based on the location of the 
research assistants. Out of these districts, four 
subdistricts were purposively selected, with 
at least one of the subdistricts an urban area. 
Urban subdistricts were defined as having a 
town or metropolitan area and a population 
of more than 200 000 people. In the Western 
Cape, subdistricts were selected from the 
metropolitan and West Coast districts to 
enable a mix of rural and urban populations.
The sample size required from each 
subdistrict to make up the total of 6 000 for 
the province was stratified according to the 
population of the subdistrict. The facilities in 
each subdistrict were then listed and divided 
into community health centres (CHCs), fixed 
clinics or mobile clinics. It was assumed 
that a larger CHC would have five HCWs 
participating in the survey, a fixed clinic two 
and a mobile clinic one. It was also assumed 
that each HCW would see at least 20 patients 
a day and collect data on 5 separate days. 
The number of HCWs required to deliver 
the sample size was then determined and 
distributed between the different types of 
facilities in proportion to the total number 
of different facilities in the subdistrict. The 
required number of CHCs, fixed clinics and 
mobile clinics were then randomly selected. 
In the Tygerberg and Klipfontein subdistricts, 
the City of Cape Town, which runs the clinics, 
refused permission for the survey and four 
CHCs were therefore selected.
Data collection
At each selected facility, the research assistant 
explained the project and invited PHC providers 
(either doctors or nurses) to participate. HCWs 
were provided with a data collection tool that 
allowed them to record the age and gender 
of each patient and up to five reasons for 
each encounter and five diagnoses for that 
consultation. No distinction was made between 
primary and secondary or ongoing diagnoses. 
HCWs had access to the medical record and 
recorded all the reasons for the encounter 
and diagnoses pertinent to the consultation. 
While chronic conditions that were considered 
active and ongoing would have been recorded, 
everything in the past medical history may not 
have been captured. HCWs were not expected 
to screen patients for undiagnosed disease. Data 
were collected on all sequential ambulatory 
patients seen by the HCW on that day. HCWs 
were expected to be working in general PHC 
and not in a specialised vertical programme or 
emergency department.
Data analysis
The International Classification of Primary 
Care, 2nd edition (ICPC-2)[12] was used 
to code all reasons for encounter and 
diagnoses. The ICPC-2 was developed by the 
World Organization of National Colleges, 
Academies and Academic Associations of 
General Practitioners/Family Physicians 
(WONCA) as a classification system 
uniquely suited to PHC. The system enables 
classification of the reasons for encounter 
and diagnoses using a biaxial structure. The 
first axis codes the body system involved by 
means of a letter derived from 17 possible 
chapters. The second axis contains seven 
components related to different aspects of 
the consultation. Within each component 
a menu of standardised rubrics are listed 
with definitions and inclusion and exclusion 
criteria. These rubrics provide a two-digit 
numerical code that is combined with the 
letter to give the final classification. For 
example, HIV/AIDS is coded as B90, type 2 
diabetes as T90 and tuberculosis as A70.
In this study, the data on NCDs were 
analysed further with the help of a statistician. 
Using an Excel spreadsheet, it was possible 
to analyse the frequency of the following 
variables for each of the targeted NCDs 
(hypertension, asthma, COPD, epilepsy and 
diabetes): age distribution and mean age, 
gender distribution, other comorbid diseases, 
and whether the consultation was with a 
nurse or a doctor. Finally, it was possible 
to calculate the percentage of patients with 
different numbers of comorbid conditions for 
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Fig. 1. Gender distribution of patients with selected NCDs.
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each index condition. In this analysis, 
comorbidity refers to the presence of 
another disease at the consultation in 
addition to the selected NCD, while 
multimorbidity refers to the presence 
of two or more such diseases.
Results
Altogether 18 856 consultations were 
included in the survey and generated 
31 451 reasons for encounter and 
24 561 diagnoses. Limpopo provided 
6 678 of the consultations (35.4%), the 
Northern Cape 1 504 (7.9%), North 
West 5 082 (26.9%) and the Western 
Cape 5 592 (29.6%). Women accoun-
ted for 12 526 (66.6%) of consultations 
and men for 6 288 (33.4%).
In the original morbidity study, 
hypertension was the most common 
diagnosis encountered in PHC, with 
2 957 (12%) having uncomplicated and 
262 (1.1%) complicated hypertension. 
Another six NCDs were in the top 
25 diagnoses seen in PHC: type 2 
diabetes 946 (3.9%), osteoarthritis 530 
(2.2%), asthma 485 (2.0%), epilepsy 
375 (1.9%) and COPD 140 (0.6%). 
The total number of patients with 
these NCDs was 5 695, of whom 3 811 
(66.9%) were seen by nurses and 1 884 
(33.1%) by doctors.
The mean age (standard devia-
tion) of patients with osteo arthritis 
was 56.9 (13.1) years, while that for 
COPD was 56.8 (10.1) years, for 
type 2 diabetes 56.6 (12.9) years, 
for hypertension 56.4 (13.3) years, 
for asthma 45.5 (18.1) years and 
for epilepsy 37.9 (16.4) years. Fig. 
1 shows the gender distribution of 
patients with NCDs. Women were 
in the majority for hypertension, 
diabetes and osteoarthritis, whereas 
there were more men with COPD 
and epilepsy.
Table 1 illustrates the top ten 
condi tions, in descending order of 
occurrence, that were comorbid 
with each of the selected NCDs. 
Hypertension was the commonest 
comorbid condition in type 2 dia-
betes, epilepsy, asthma and COPD. 
Diabetes and hypertension was the 
commonest combination.
Table 2 and Fig. 2 show the 
extent of multimorbidity for each 
NCD. This table includes patients 
with type 1 and type 2 diabetes as 
well as all forms of osteoarthritis. 
Comorbidity with ICPC codes for 
other diseases and tumours were 
included in the calculation, while T
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infections, injuries and congenital conditions 
were excluded. Overall, 48.4% of patients 
presented with comorbid conditions at 
the consultation, although the majority 
(34.0%) had only one additional condition. 
Multimorbidity was present overall in 14.4% 
of consultations: in 36.4% of patients with 
COPD, 23.7% with osteoarthritis, 16.3% with 
diabetes, 15.3% with asthma, 12.0% with 
hypertension and 6.7% with epilepsy.
Of the patients with NCDs, only 1.1% 
were also diagnosed with HIV, 1.0% with TB, 
0.4% with depression and 0.04% with anxiety 
disorders.
Discussion
Comorbidity was present in almost half 
of the patients with NCDs and presents a 
challenge that all HCWs should be aware 
of. Comorbidity in patients with NCDs 
ranged from 65.2% of people with diabetes to 
24.5% of people with epilepsy. Hypertension 
was the commonest comorbid condition. 
Multimorbidity was found in 14.4% of 
patients, varying from 36.4% in COPD to 
6.7% in those with epilepsy. Patients of older 
age had greater levels of comorbidity.
Although multimorbidity is clearly an issue, 
the extent of the challenge to clinical care is not 
on the same scale as that in Europe or North 
America. For example, in Scotland 47% of 
patients with diabetes were found to have three 
or more comorbid NCDs compared with only 
5% of patients in this study,[9] a possible reason 
being a more elderly Scottish population, with 
longer life expectancy. Better access to and 
quality of PHC may also have led to better 
diagnosis and documentation of comorbid 
conditions in Scotland. It is likely that many 
NCDs went undiagnosed in contemporary SA 
PHC and were therefore not counted, the level 
of comorbidity reported here almost certainly 
being an underestimate of the true picture. It is 
also likely that multimorbidity will increase as 
SA life expectancy increases.
Mental health disorders such as depression 
and anxiety were found in 40% of patients in 
the Scottish study, but were hardly recognised 
in the SA context.[7] A recent study of people 
with hypertension in SA found that 8.1% had 
had an anxiety disorder and 4.9% a depressive 
disorder during the previous 12 months.
[13] Psychological problems also increase in 
relation to the extent of multimorbidity.[14] 
The low comorbidity with mental disorders 
found in this study therefore probably reflects 
poor ability to recognise these disorders.
Despite concerns in SA about emerging 
co morbidity between HIV and NCDs, this 
study suggested that the problem appears 
very small among patients with NCDs 
attending ambu latory PHC. In the age group 
50 - 60 years, the prevalence of HIV in the 
population is between 10% and 15%,[15] and 
as the morbidity survey excluded patients 
with HIV who were being seen in a separate 
vertical programme, the results cannot shed 
light on comorbidity among patients with 
HIV.[7] Notably, there is work that suggests 
that 30% of older patients with HIV may have 
comorbidity with other chronic diseases.[16] It is 
also possible that treatment for NCDs is being 
given to HIV-positive patients in HIV clinics. 
Future research is required to investigate these 
comorbid conditions within the HIV context, 
especially as HIV-positive patients who were 
diagnosed in young adulthood mature.
Most patients with TB are also treated 
separately and yet would still need to attend 
ambulatory PHC for treatment of any 
comorbid NCDs. The current incidence of 
TB of approximately 1%[17] would be broadly 
consistent with the rate found among patients 
with NCDs in this study.
Multimorbidity increases the complexity 
of clinical care, as guidelines for different 
diseases must be integrated and rationalised 
for management of a specific patient with their 
own preferences and perspective. Patients 
should be managed holistically, and all their 
medical problems attended to by a competent 
generalist, rather than risk fragmenting care 
between different services and consultations; 
patients also deserve their own goals, concerns 
and preferences to be taken into account.[10] 
The ability to deliver such care is a challenge, 
as most are seen by nurses with limited 
training in the management of NCDs.[18] The 
PHC system will need to look at guidelines 
that support a more integrated approach, such 
as the PC101 PHC guidelines,[19] and the 
availability of PHC doctors to assist with more 
complex patients.[20]
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Fig. 2. The extent of multimorbidity in patients with NCDs. 
Table 2. Multimorbidity in NCDs
Comorbid diseases, n
0 1 2 3 4
Hypertension (N=3 219), n (%) 1 822 (56.6) 1 012 (31.4) 294 (9.1) 89 (2.8) 2 (0.1)
Diabetes (N=999), n (%) 348 (34.8) 488 (48.8) 109 (10.9) 52 (5.2) 2 (0.2)
Asthma (N=485), n (%) 265 (54.6) 146 (30.1) 61 (12.6) 13 (2.7) 0 (0.0)
Epilepsy (N=375), n (%) 283 (75.5) 67 (17.9) 18 (4.8) 7 (1.9) 0 (0.0)
COPD (N=140), n (%) 51 (36.4) 38 (27.1) 35 (25.0) 15 (10.7) 1 (0.7)
Osteoarthritis (N=575), n (%) 218 (37.9) 221 (38.4) 100 (17.4) 35 (6.1) 1 (0.2)
All (N=5 793), n (%) 2 987 (51.6) 1 972 (34.0) 617 (10.7) 211 (3.6) 6 (0.1)
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Improved training, especially when it comes to prescribing, will 
be necessary as multimorbidity increases. Clinicians often find 
it difficult to balance the benefits of certain medications with 
the potential risks of the specific medication or the interaction it 
may have with existing medications.[21] For example, in patients 
with hypertension in PHC, 73% of scripts have potential drug-
drug interactions, with 7% of these being potentially severe; 
in patients with diabetes, 81% of patients have potential drug-
drug interactions, 12% of which are potentially severe.[21] 
Guidelines take individual conditions into account, but combining 
recommendations can potentially be harmful in patients with 
several NCDs. The question whether nurses are adequately trained 
to manage the potentially complicated patient with numerous 
NCDs therefore arises. The evidence tends to suggest that nurses/
nurse practitioners do well when using guidelines to manage single 
diseases,[22] but little evidence exists to suggest the same when it 
comes to multimorbidity. The role of the family physician may 
be important in assisting with the clinical care of these patients 
through consultations, mentoring of nurses/nurse practitioners, 
and clinical governance activities.[23] Family physicians may offer 
a more patient-centred and biopsychosocial approach, as a result 
of their generalist training.
Study limitations
Not all the provinces in SA were represented in the study, so the 
findings may not be applicable to the entire population. Districts 
and subdistricts were not randomly selected, which could influence 
the results. The sample in the Northern Cape, because of a shortage 
of staff, was significantly smaller than originally anticipated. The 
findings are derived from the public sector and are likely to be 
different in the private sector.
The data represent what has been recognised and documented in 
PHC and is not necessarily an accurate picture of multimorbidity 
in the community overall. Some regions in SA are better resourced 
for the screening and diagnosis of NCDs (e.g. the Western Cape), 
as a result of which the degree of multimorbidity recognised might 
be greater than in other areas. The findings represent conditions 
that had been diagnosed (no screening for undiagnosed conditions 
was asked for) and were considered to be active and ongoing at 
that consultation. The results therefore represent the practical 
comorbidity that needed to be managed, rather than the total 
comorbidity that might have been present had all conditions been 
looked for and included.
Implications and recommendations
• Guidelines for the management of patients with NCDs should 
take cognisance of the common comorbid conditions found in 
SA PHC.
• Multimorbidity in patients with NCDs needs to be monitored, as it 
is likely to increase as life expectancy increases.
• Further research is needed to evaluate the capability of nurses/
nurse practitioners in managing comorbidity and to consider care 
pathways in PHC that involve doctors appropriately.
• Future research may aim to accurately determine the degree of 
multimorbidity, when all diseases of interest may be actively looked 
for under ideal study conditions, as opposed to the pragmatic, real-
life conditions employed in this study. This would throw light on 
the extent to which PHC is currently recognising comorbidity and 
the quality of care provided.
• Because recognition of mental disorders in patients with NCDs is 
likely to be low, attention should be given to better recognition, 
diagnosis and management of such conditions.
Conclusion
The study set out to determine the prevalence of multimorbidity 
among patients with common NCDs (diabetes, hypertension, 
asthma, osteoarthritis, epilepsy, COPD) in SA. Overall 48.4% of 
patients consulted had at least one comorbid condition, while 
14.4% had multimorbidity. Findings showed a lower prevalence of 
multimorbidity relative to that found in high-income countries. 
Rates of comorbidity ranged from 65.2% of patients with diabetes 
to 24.5% of patients with epilepsy. There was a lower than expected 
relationship between NCDs and psychiatric conditions. Hypertension 
was strongly comorbid with diabetes, COPD, asthma and epilepsy. 
Since patients with NCDs were mostly seen by nurses, future training 
and guidelines should address the complexity inherent in their 
consultations. Greater involvement of doctors in managing more 
complicated patients with multimorbidity should also be considered.
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